A Review On Ankylosing Spondylitis

Authors

  • V. SANTHOSH KUMAR Department of Pharmacology, National Institute of Pharmaceutical Education and Research, Guwahati, India
  • SUKIRTI DAS Department of Pharmacy, Gauhati Medical College, Guwahati, India.
  • T.SAI SAMPATH Department of Pharmacology, National Institute of Pharmaceutical Education and Research, Guwahati, India.

Keywords:

Ankylosing spondylitis, HLA-B27, infliximab, IL-1&IL-27,TNF-α.

Abstract

Ankylosing spondylitis is a chronic autoinflammmatory disease of the joints, belonging to the group of spondyloarthropathic disorders. The disease has a crippling effect on the axial skeleton and its progression to the later stages can have a debilitating effect on the patient. It has an under-diagnosed pathology and enigmatic pathophysiology. A strong genetic link has been found with the help of genome screening. Evidence of proinflammatory cytokines has been suggested but the unique aspect is that inflammation and structural progression are partly independent. DMARDS, NSAIDS produce symptomatic relief and anti-TNF therapy shows promising results. Current research has to delve deep into the pathophysiology for development of an ideal, curative therapy.

Published

30.09.2011

How to Cite

V. SANTHOSH KUMAR, SUKIRTI DAS, & T.SAI SAMPATH. (2011). A Review On Ankylosing Spondylitis. International Journal of Pharma and Bio Sciences, 2(3), 186–193. Retrieved from https://ijpbs.net/index.php/journal/article/view/890

Issue

Section

Research Articles

Categories